"Le Centre Hospitalier de Bourg-en-Bresse (CHB) est un établissement de Médecine-Chirurgie-Obstétrique qui compte plus de 900 lits et places, plus de 2 419 professionnels répartis au sein de ses 7 pôles d’activités médicales : Médecine, Chirurgie, Cancérologie, Soins Critiques, Mère-Enfant, Transversal & Support et Gériatrie. Chaque année, le CHB gère également près de 300 000 appels entrants au SAMU 01, plus de 137 000 consultations (hors imagerie, CSP, urgences), plus de 47 000 passages aux Urgences, plus de 12 000 patients sont reçus au bloc opératoire. 120 résidents sont accueillis en USLD et 169 en EHPAD. www .ch-bourg-en-bresse.fr LinkedIN : Centre hospitalier de Bourg-en-Bresse"
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Ch De Fleyriat; Pneumologie 1
During the past decade, Ch De Fleyriat; Pneumologie 1 conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment
An Efficacy Study of 2',3'-Dideoxyinosine (ddI) (BMY-40900) Administered Orally Twice Daily to Zidovudine Intolerant Patients With AIDS or AIDS-Related Complex
A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARC
Safety and Efficacy of Zidovudine for Asymptomatic HIV-Infected Individuals
1995-02-01
Completed
3,200
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Ch De Fleyriat; Pneumologie 1
According to Clinical.Site data, the most researched conditions in "Ch De Fleyriat; Pneumologie 1" are
"Breast Neoplasms" (1 trials) and "Non-Squamous Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Ch De Fleyriat; Pneumologie 1" in a lesser frequency.
Clinical Trials Intervention Types at Ch De Fleyriat; Pneumologie 1
Most popular intervention types in "Ch De Fleyriat; Pneumologie 1" are "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Herceptin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Ch De Fleyriat; Pneumologie 1
The vast majority of trials in "Ch De Fleyriat; Pneumologie 1" are
2 trials for "All" genders.
Clinical Trials Status at Ch De Fleyriat; Pneumologie 1
Currently, there are NaN active trials in "Ch De Fleyriat; Pneumologie 1".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Ch De Fleyriat; Pneumologie 1,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Ch De Fleyriat; Pneumologie 1, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".